CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 100 filers reported holding CULLINAN ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,245 | -97.6% | 1,574 | -97.1% | 0.00% | – |
| Q2 2023 | $590,961 | -46.8% | 54,922 | -49.4% | 0.00% | – |
| Q1 2023 | $1,110,406 | +19.1% | 108,544 | +22.8% | 0.00% | – |
| Q4 2022 | $932,472 | -43.9% | 88,386 | -31.8% | 0.00% | – |
| Q3 2022 | $1,661,000 | -39.5% | 129,534 | -39.5% | 0.00% | – |
| Q2 2022 | $2,744,000 | -83.9% | 214,066 | -86.9% | 0.00% | -100.0% |
| Q1 2022 | $17,057,000 | +17.6% | 1,629,180 | +73.3% | 0.00% | 0.0% |
| Q4 2021 | $14,505,000 | -74.3% | 940,040 | -62.4% | 0.00% | -75.0% |
| Q3 2021 | $56,430,000 | +10.8% | 2,500,212 | +26.4% | 0.00% | 0.0% |
| Q2 2021 | $50,931,000 | +0.2% | 1,977,907 | +62.1% | 0.00% | 0.0% |
| Q1 2021 | $50,845,000 | – | 1,220,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |